James E. Monroe

669 total citations
15 papers, 465 citations indexed

About

James E. Monroe is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, James E. Monroe has authored 15 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in James E. Monroe's work include Herpesvirus Infections and Treatments (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and HIV Research and Treatment (3 papers). James E. Monroe is often cited by papers focused on Herpesvirus Infections and Treatments (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and HIV Research and Treatment (3 papers). James E. Monroe collaborates with scholars based in United States, South Africa and Belgium. James E. Monroe's co-authors include Carel Mulder, Anders Lilja, Alain Calender, Peter G. Medveczky, John L. Sullivan, Andrea Carfı́, Sumana Chandramouli, Stephen J. Forman, Peter W. Mason and Susan W. Barnett and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Biochemistry.

In The Last Decade

James E. Monroe

15 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Monroe United States	10	272	124	116	102	102	15	465
A Arvin United States	12	471 1.7×	60 0.5×	96 0.8×	58 0.6×	125 1.2×	34	545
Shek Graham United Kingdom	9	383 1.4×	60 0.5×	311 2.7×	60 0.6×	72 0.7×	9	589
Takahiro Niizuma Japan	12	201 0.7×	70 0.6×	63 0.5×	36 0.4×	37 0.4×	36	385
H Závadová Czechia	10	297 1.1×	125 1.0×	79 0.7×	169 1.7×	35 0.3×	43	456
Allen Ka Loon Cheung Hong Kong	13	331 1.2×	122 1.0×	257 2.2×	89 0.9×	152 1.5×	36	605
Rebecca LaFond United States	7	183 0.7×	67 0.5×	308 2.7×	30 0.3×	61 0.6×	9	511
Petra Tunbäck Sweden	15	340 1.3×	58 0.5×	105 0.9×	40 0.4×	102 1.0×	34	491
L. Simoncini Italy	13	491 1.8×	305 2.5×	58 0.5×	215 2.1×	59 0.6×	14	788
Kirsten K. Dietze Germany	15	210 0.8×	91 0.7×	549 4.7×	121 1.2×	97 1.0×	16	728
Christopher S. Morello United States	16	616 2.3×	106 0.9×	270 2.3×	31 0.3×	69 0.7×	19	765

Countries citing papers authored by James E. Monroe

Since Specialization

Citations

This map shows the geographic impact of James E. Monroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Monroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Monroe more than expected).

Fields of papers citing papers by James E. Monroe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Monroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Monroe. The network helps show where James E. Monroe may publish in the future.

Co-authorship network of co-authors of James E. Monroe

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Monroe. A scholar is included among the top collaborators of James E. Monroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Monroe. James E. Monroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Steff, Ann‐Muriel, James E. Monroe, Sumana Chandramouli, et al.. (2017). Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV. Nature Communications. 8(1). 1085–1085. 28 indexed citations

2.

Chandramouli, Sumana, Claudio Ciferri, Pavel A. Nikitin, et al.. (2015). Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody. Nature Communications. 6(1). 8176–8176. 98 indexed citations

3.

Wen, Yingxia, James E. Monroe, Jacob Archer, et al.. (2014). Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice. Vaccine. 32(30). 3796–3804. 68 indexed citations

4.

Loomis, Rebecca J., Anders Lilja, James E. Monroe, et al.. (2012). Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies. Vaccine. 31(6). 919–926. 35 indexed citations

5.

Shephard, Enid, Wendy A. Burgers, James E. Monroe, et al.. (2008). A Multigene HIV Type 1 Subtype C Modified Vaccinia Ankara (MVA) Vaccine Efficiently Boosts Immune Responses to a DNA Vaccine in Mice. AIDS Research and Human Retroviruses. 24(2). 207–217. 23 indexed citations

6.

Burgers, Wendy A., Enid Shephard, James E. Monroe, et al.. (2008). Construction, Characterization, and Immunogenicity of a Multigene Modified Vaccinia Ankara (MVA) Vaccine Based on HIV Type 1 Subtype C. AIDS Research and Human Retroviruses. 24(2). 195–206. 39 indexed citations

7.

Monroe, James E., et al.. (1996). Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication. Antiviral Research. 29(2-3). 243–260. 13 indexed citations

8.

Crute, James J., I Lehman, Joseph Gambino, et al.. (1995). Inhibition of Herpes Simplex Virus Type 1 Helicase-Primase by (Dichloroanilino)purines and -pyrimidines. Journal of Medicinal Chemistry. 38(10). 1820–1825. 8 indexed citations

9.

Monroe, James E.. (1988). Generalization and maintenance in therapeutic systems: Analysis and proposal for change.. Professional Psychology Research and Practice. 19(4). 449–453. 3 indexed citations

10.

Monroe, James E., Alain Calender, & Carel Mulder. (1988). Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2. Journal of Virology. 62(9). 3497–3500. 43 indexed citations

11.

Monroe, James E.. (1988). Generalization and maintenance in therapeutic systems: Analysis and proposal for change.. Professional Psychology Research and Practice. 19(4). 449–453. 3 indexed citations

12.

Monroe, James E., Charla Andrews, J L Sullivan, & Carel Mulder. (1987). Use of Cytoplasmic Dot-Blot Hybridization to Detect Human Immunodeficiency Virus RNA Sequences in Cultures of Peripheral Blood. The Journal of Infectious Diseases. 155(2). 320–322. 14 indexed citations

13.

Monroe, James E. & William J. McCarthy. (1984). Polypeptide analysis of genotypic variants of occluded Heliothis spp. baculoviruses. Journal of Invertebrate Pathology. 43(1). 32–40. 9 indexed citations

14.

Sullivan, John L., et al.. (1984). Epstein–Barr-Virus Induced Lymphoproliferation. New England Journal of Medicine. 311(18). 1163–1167. 73 indexed citations

15.

Miller, Wilmer G. & James E. Monroe. (1968). Enzymic hydrolysis of synthetic polypeptides under high helical content. Biochemistry. 7(1). 253–261. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact